(Q51371295)

4 April 2018

title

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. (English)

1 reference

4 April 2018

progressive supranuclear palsy

main subject

multiple system atrophy

1 reference

based on heuristic

inferred from title

1 reference

Pirker W

1

1 reference

4 April 2018

Asenbaum S

2

1 reference

4 April 2018

Bencsits G

3

1 reference

4 April 2018

Prayer D

4

1 reference

4 April 2018

Gerschlager W

5

1 reference

4 April 2018

Deecke L

6

1 reference

4 April 2018

Brücke T

7

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 November 2000

1 reference

4 April 2018

published in

Movement Disorders

1 reference

4 April 2018

volume

15

1 reference

4 April 2018

issue

6

1 reference

4 April 2018

page(s)

1158-1167

1 reference

4 April 2018

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

[125I]RTI-55: a potent ligand for dopamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

10.1002/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018